IBDEI0VK ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31756,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,31757,0)
 ;;=L21.9^^119^1553^263
 ;;^UTILITY(U,$J,358.3,31757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31757,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,31757,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,31757,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,31758,0)
 ;;=L23.7^^119^1553^30
 ;;^UTILITY(U,$J,358.3,31758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31758,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,31758,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,31758,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,31759,0)
 ;;=L23.9^^119^1553^31
 ;;^UTILITY(U,$J,358.3,31759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31759,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,31759,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,31759,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,31760,0)
 ;;=L24.9^^119^1553^163
 ;;^UTILITY(U,$J,358.3,31760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31760,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,31760,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,31760,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,31761,0)
 ;;=L25.9^^119^1553^115
 ;;^UTILITY(U,$J,358.3,31761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31761,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,31761,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,31761,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,31762,0)
 ;;=L26.^^119^1553^148
 ;;^UTILITY(U,$J,358.3,31762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31762,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,31762,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,31762,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,31763,0)
 ;;=L27.0^^119^1553^265
 ;;^UTILITY(U,$J,358.3,31763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31763,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,31763,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,31763,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,31764,0)
 ;;=L27.1^^119^1553^266
 ;;^UTILITY(U,$J,358.3,31764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31764,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,31764,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,31764,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,31765,0)
 ;;=L29.0^^119^1553^250
 ;;^UTILITY(U,$J,358.3,31765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31765,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,31765,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,31765,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,31766,0)
 ;;=L29.9^^119^1553^251
 ;;^UTILITY(U,$J,358.3,31766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31766,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,31766,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,31766,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,31767,0)
 ;;=L30.0^^119^1553^232
 ;;^UTILITY(U,$J,358.3,31767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31767,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,31767,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,31767,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,31768,0)
 ;;=L30.1^^119^1553^140
 ;;^UTILITY(U,$J,358.3,31768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31768,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,31768,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,31768,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,31769,0)
 ;;=L30.2^^119^1553^132
 ;;^UTILITY(U,$J,358.3,31769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31769,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,31769,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,31769,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,31770,0)
 ;;=L30.4^^119^1553^144
 ;;^UTILITY(U,$J,358.3,31770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31770,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,31770,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,31770,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,31771,0)
 ;;=L30.8^^119^1553^135
 ;;^UTILITY(U,$J,358.3,31771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31771,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,31771,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,31771,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,31772,0)
 ;;=L30.9^^119^1553^136
 ;;^UTILITY(U,$J,358.3,31772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31772,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,31772,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,31772,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,31773,0)
 ;;=L40.0^^119^1553^253
 ;;^UTILITY(U,$J,358.3,31773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31773,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,31773,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,31773,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,31774,0)
 ;;=L40.1^^119^1553^256
 ;;^UTILITY(U,$J,358.3,31774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31774,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,31774,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,31774,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,31775,0)
 ;;=L40.2^^119^1553^11
 ;;^UTILITY(U,$J,358.3,31775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31775,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,31775,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,31775,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,31776,0)
 ;;=L40.3^^119^1553^255
 ;;^UTILITY(U,$J,358.3,31776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31776,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,31776,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,31776,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,31777,0)
 ;;=L40.4^^119^1553^157
 ;;^UTILITY(U,$J,358.3,31777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31777,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,31777,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,31777,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,31778,0)
 ;;=L40.8^^119^1553^252
 ;;^UTILITY(U,$J,358.3,31778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31778,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,31778,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,31778,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,31779,0)
 ;;=L40.9^^119^1553^254
 ;;^UTILITY(U,$J,358.3,31779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31779,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,31779,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,31779,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,31780,0)
 ;;=L50.9^^119^1553^286
 ;;^UTILITY(U,$J,358.3,31780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31780,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,31780,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,31780,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,31781,0)
 ;;=L53.8^^119^1553^147
 ;;^UTILITY(U,$J,358.3,31781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31781,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,31781,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,31781,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,31782,0)
 ;;=L53.9^^119^1553^146
 ;;^UTILITY(U,$J,358.3,31782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31782,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,31782,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,31782,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,31783,0)
 ;;=L54.^^119^1553^145
 ;;^UTILITY(U,$J,358.3,31783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31783,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,31783,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,31783,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,31784,0)
 ;;=L56.0^^119^1553^139
 ;;^UTILITY(U,$J,358.3,31784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31784,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,31784,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,31784,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,31785,0)
 ;;=L56.1^^119^1553^138
 ;;^UTILITY(U,$J,358.3,31785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31785,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,31785,1,4,0)
 ;;=4^L56.1
